← back to search

Hao Jiang

King University · US
Area of research
Hematology · Public Health, Environmental and Occupational Health
Research interest
Research focused on Immune thrombocytopenia and Neutropenia, with related work in Sarcopenia, Decitabine, Sevoflurane. Notable publications include 'Flumatinib versus Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Phase III, Randomized, Open-label, Multi-center FESTnd Study', 'A life-threatening bleeding prediction model for immune thrombocytopenia based on personalized machine learning: a nationwide prospective cohort study', and '65P Camrelizumab combined with paclitaxel and nedaplatin as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma (ESPRIT): A phase II, single-arm,...'.
h-index
citations
103
works
9
NIH funding
primary concept
email

Recent publications

A Review of Nano‐Calcium Carbonate and Its Applications: Preparation, Necessities, Biomedicine, and Environment
Particle & Particle Systems Characterization 2025cited by 3position: middledoi
Sarcopenia predicts immune-related adverse events due to anti-PD-1/PD-L1 therapy in patients with advanced lung cancer
Frontiers in Oncology 2024cited by 9position: middledoi
A life-threatening bleeding prediction model for immune thrombocytopenia based on personalized machine learning: a nationwide prospective cohort study
Science Bulletin 2023cited by 17position: middledoi
Decitabine in patients with myelodysplastic syndromes: A multi‐center, open‐label, dose comparison trial
Cancer Medicine 2023cited by 5position: middledoi
65P Camrelizumab combined with paclitaxel and nedaplatin as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma (ESPRIT): A phase II, single-arm, exploratory research
Annals of Oncology 2021cited by 12position: middledoi
Camrelizumab combined with paclitaxel and nedaplatin as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma (ESPRIT): A phase Ⅱ, single-arm, exploratory research.
Journal of Clinical Oncology 2021cited by 9position: middledoi
405 Camrelizumab combined with paclitaxel and nedaplatin as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma (ESPRIT): a phase II, single-arm, exploratory research
Regular and Young Investigator Award Abstracts 2021cited by 2position: middledoi
406 Camrelizumab combined with paclitaxel and nedaplatin in the first-line treatment of locally advanced/advanced esophageal squamous cell carcinoma: a phase II, single-arm, exploratory research
Regular and Young Investigator Award Abstracts 2021cited by 1position: middledoi
Flumatinib versus Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Phase III, Randomized, Open-label, Multi-center FESTnd Study
Clinical Cancer Research 2020cited by 55position: middledoi
Risk stratification and outcomes of intracranial hemorrhage in patients with immune thrombocytopenia under 60 years of age
Platelets 2020cited by 8position: middledoi
A risk score for predicting hospitalization for community-acquired pneumonia in ITP using nationally representative data
Blood Advances 2020cited by 6position: middledoi
Application of sevoflurane inhalation combined with epidural anesthesia in patients with colorectal cancer and its effect on postoperative perceptual function
Oncology Letters 2019cited by 4position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Wei Zheng · Harbin Medical University4 papers (2021–2021)Jianqun Ma · Nantong University4 papers (2021–2021)Chengyuan Fang · Harbin Medical University4 papers (2021–2021)Xiaodong Ling · Harbin Medical University4 papers (2021–2021)Dayong Zheng · Guangzhou University of Chinese Medicine3 papers (2021–2021)Yanzhong Xin · Harbin Medical University3 papers (2021–2021)Yingnan Yang · Harbin Medical University3 papers (2021–2021)Luquan Zhang · Harbin Medical University3 papers (2021–2021)Xiaoyuan Wang · National University of Singapore3 papers (2021–2021)Jinfeng Zhang · Nanchang University3 papers (2021–2021)Hongxue Meng · Harbin Medical University2 papers (2021–2021)Hao Liang · Jinan University2 papers (2021–2021)Kang Yu · Wenzhou Medical University1 papers (2023–2023)Yanyong Yang · The University of Texas Southwestern Medical Center1 papers (2021–2021)Zhimin Zhai · Anhui Medical University1 papers (2023–2023)Hui Sun · Harbin Medical University1 papers (2023–2023)Hai Bai · Shanxi Datong University1 papers (2023–2023)Hao Liang · Guangzhou University of Chinese Medicine1 papers (2021–2021) · 1 papers (2023–2023)Zhuogang Liu · Union Hospital1 papers (2023–2023)